Abstract:OBJECTIVE:To determine the different rates of human papillomavirus types 6 (HPV-6) and 11 (HPV-11) infection in biopsy samples from pointed condyloma patients, and to construct prokaryotic expression system of the major capsid protein L1 of the virus so as to establish an ELISA for detecting the expression of L1 gene in the biopsy samples.METHODS:Using a double PCR based on the L1 gene of HPV-6 and HPV-11, the infection rates of HPV-6 and HPV-11 in the biopsy samples were determined. The whole length of HPV-6 L1 gene was amplified using PCR and the target amplification fragment was sequenced after T-A cloning. The prokaryotic expression system pET32a-L1-E. coli BL21 (DE3) was constructed and SDS-PAGE was used to measure the expression of the target recombinant protein rL1. Rabbit anti-rL1 serum was prepared and immuno-diffusion assay was applied to examine the antiserum titer. ELISA was established to detect the expression of L1 gene in the biopsy samples.RESULTS:In the biopsy samples from 116 pointed condyloma patients, 92.2% (107/116) were detectable for HPV-6 and/or HPV-11. Of the 107 positive samples, 70.1% (75/107) and 23.4% (25/107) were positive for HPV-6 or HPV-11 alone and 6.5% (7/107) were coinfected with both HPV-6 and HPV-11 respectively. When compared with the reported corresponding sequences, the homology of nucleotide and sequence of the cloned HPV-6 L1 gene was from 99.20% - 99.93% while its putative amino acid sequence homology was from 99.80% - 100%, suggesting IPTG could induce the expression of rL1. The immuno-diffusion titer of the rabbit anti-rL1 serum was 1:4. 88.8% (103/116) of the biopsy samples were the major capsid protein L1 detectable.CONCLUSION:A prokaryotic expression system of HPV-6 L1 gene, a double PCR assay for HPV-6 and HPV-11 genotyping, and an ELISA assay for detecting the major capsid protein L1 were successfully established in this study. The pointed condyloma patients in Zhejiang area mainly infected with HPV-6. The HPV in the focus frequently expressed major capsid protein L1.

Expression of HPV6b L1/EBV LMP2 Multiepitope and Immunogenicity in Mice.

Construction, Expression, Purification and Identification of Chimeric HPV16 E7-L1 Virus Like Particles

The humoral and cellular immune responses induced by HPV18L1-E6/E7 DNA vaccines in mice

Screening and identification of B cell epitope within the major capsid protein L1 of HPV 52, using monoclonal antibodies

The construction of HPV16 E6 eukaryotic expression plasmid pcDNA3/E6 and its immunogenecity evaluation on animals

Human Papillomavirus L1 Protein Expressed in Escherichia Coli Self-Assembles into Virus-Like Particles That Are Highly Immunogenic.

Construction of a Chimeric Gene of Human Papillomavirus Type 16 L1-E7 and Immunogenicity of Expressed Fusion Protein

Mapping the B Cell Epitopes Within the Major Capsid Protein L1 of Human Papillomavirus Type 16.

[Study on the Frequency of Human Papillomavirus Type 6 and Type 11 Infection and L1 Gene Expression of the Virus in Biopsy Samples of Pointed Condyloma Patients].

Gene Optimization is Necessary to Express HPV Type 6 L1 Protein in the Methylotrophic Yeast Pichia Pastoris

Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice

The Specific Immune Response Elicited by Recombinant CRT120/HPV6bE7 DNA Vaccine in Mice

The construction of HPV16-L1 recombinant plasmid and its expression in mammalian cells

Expression of Genetically Modified Human Papillomavirus Type 58 L1 Gene and Production of Antisera Against Resultant VLP

[Preliminary Study of HPV16 L1/E6-E7 Chimeric Recombinant DNA Vaccine Plasmid Construction and Expression in CHO Cell].

Prokaryotic Expression and Purification of Minor Capsid Protein L2 Derived from Human Papillomavirus 58 and Preparation of Monoclonal Antibody

[Cloning and Expressing of Human Papillomavirus 16 E7C Subgene].

One-prime Multi-Boost Strategy Immunization with Recombinant DNA, Adenovirus, and MVA Vector Vaccines Expressing HPV16 L1 Induces Potent, Sustained, and Specific Immune Response in Mice.

Immunoinformatics Design and In Vivo Immunogenicity Evaluation of a Conserved CTL Multi-Epitope Vaccine Targeting HPV16 E5, E6, and E7 Proteins

Epitomics: IgG-epitome Decoding of E6, E7 and L1 Proteins from Oncogenic Human Papillomavirus Type 58

Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice